Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2010 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Prepaid Assets came in at $1.1 million in Q1 2026, down 1.48% YoY from $1.1 million in Q1 2025, and down 80.88% on a QoQ basis from $5.9 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 17 years of Prepaid Assets data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Prepaid Assets fell 1.48% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 1.48% YoY) and the FY2025 annual result came in at $5.9 million, down 25.67% from the prior year.
- Prepaid Assets slipped to $1.1 million in Q1 2026, from $5.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $28.1 million in Q3 2025 to a low of $351000.0 in Q4 2023.
- A 5-year average of $7.7 million and a median of $5.2 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets sank 96.5% — and 2025, when it jumped 5651.12%.
- Tracing CPRX's Prepaid Assets over 5 years: stood at $5.2 million in 2022, then tumbled by 93.21% to $351000.0 in 2023, then jumped by 2167.52% to $8.0 million in 2024, then declined by 25.67% to $5.9 million in 2025, then sank by 80.88% to $1.1 million in 2026.
- The last three Prepaid Assets figures came in at $1.1 million (Q1 2026), $5.9 million (Q4 2025), and $28.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 28.12 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 7.96 Mn |
| Sep 30, 2024 | 489,000.00 |
| Jun 30, 2024 | 23.55 Mn |
| Mar 31, 2024 | 13.75 Mn |
| Dec 31, 2023 | 351,000.00 |
| Sep 30, 2023 | 13.96 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Mar 31, 2023 | 6.93 Mn |
| Dec 31, 2022 | 5.17 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 5.02 Mn |
| Dec 31, 2021 | 4.35 Mn |
| Sep 30, 2021 | 4.43 Mn |
| Jun 30, 2021 | 7.64 Mn |